메뉴 건너뛰기




Volumn 45, Issue 2, 2009, Pages 55-57

Inflammatory demyelinating events following treatment with anti-tumor necrosis factor

Author keywords

Demyelinating events; Multiple sclerosis; Optic neuritis; Tumor necrosis factor alpha

Indexed keywords

ADALIMUMAB; BETA1A INTERFERON; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; OXCARBAZEPINE; PREDNISONE; TUMOR NECROSIS FACTOR ANTIBODY;

EID: 59249098388     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.11.002     Document Type: Review
Times cited : (112)

References (26)
  • 1
    • 0028288398 scopus 로고
    • Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA
    • Roth M.P., Nogueira L., Coppin H., Clanet M., Clayton J., and Cambon-Thomsen A. Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol 51 (1994) 93-99
    • (1994) J Neuroimmunol , vol.51 , pp. 93-99
    • Roth, M.P.1    Nogueira, L.2    Coppin, H.3    Clanet, M.4    Clayton, J.5    Cambon-Thomsen, A.6
  • 2
    • 0035674613 scopus 로고    scopus 로고
    • Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritis
    • Mohan N., Edwards E.T., Cupps T.R., Oliverio P.J., Sandberg G., Crayton H., et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritis. Arthritis Rheum 44 (2001) 2862-2869
    • (2001) Arthritis Rheum , vol.44 , pp. 2862-2869
    • Mohan, N.1    Edwards, E.T.2    Cupps, T.R.3    Oliverio, P.J.4    Sandberg, G.5    Crayton, H.6
  • 3
    • 0035960624 scopus 로고    scopus 로고
    • Onset of multiple sclerosis associated with anti-TNF therapy
    • Sicotte N.L., and Voskuhl R.R. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57 (2001) 1885-1888
    • (2001) Neurology , vol.57 , pp. 1885-1888
    • Sicotte, N.L.1    Voskuhl, R.R.2
  • 4
    • 0033546665 scopus 로고    scopus 로고
    • TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1999;53: 457-65.
    • TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1999;53: 457-65.
  • 5
    • 0030832846 scopus 로고    scopus 로고
    • Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
    • Barkhof F., Filippi M., Miller D.H., Scheltens P., Campi A., Polman C.H., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (1997) 2059-2069
    • (1997) Brain , vol.120 , pp. 2059-2069
    • Barkhof, F.1    Filippi, M.2    Miller, D.H.3    Scheltens, P.4    Campi, A.5    Polman, C.H.6
  • 6
    • 28544436950 scopus 로고    scopus 로고
    • Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"
    • Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58 (2005) 840-846
    • (2005) Ann Neurol , vol.58 , pp. 840-846
    • Polman, C.H.1    Reingold, S.C.2    Edan, G.3    Filippi, M.4    Hartung, H.P.5    Kappos, L.6
  • 8
    • 0038109994 scopus 로고    scopus 로고
    • Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study
    • Vermeire S., Noman M., Van Assche G., Baert F., Van Steen K., Esters N., et al. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology 125 (2003) 32-39
    • (2003) Gastroenterology , vol.125 , pp. 32-39
    • Vermeire, S.1    Noman, M.2    Van Assche, G.3    Baert, F.4    Van Steen, K.5    Esters, N.6
  • 11
    • 33644774314 scopus 로고    scopus 로고
    • Optic neuritis associated with etanercept therapy for juvenile arthritis
    • Tauber T., Turetz J., Barash J., Avni I., and Morad Y. Optic neuritis associated with etanercept therapy for juvenile arthritis. J AAPOS 10 (2006) 26-29
    • (2006) J AAPOS , vol.10 , pp. 26-29
    • Tauber, T.1    Turetz, J.2    Barash, J.3    Avni, I.4    Morad, Y.5
  • 12
    • 32944477248 scopus 로고    scopus 로고
    • Anti-tumor necrosis factor alpha-associated multiple sclerosis
    • Titelbaum D.S., Degenhardt A., and Kinkel R.P. Anti-tumor necrosis factor alpha-associated multiple sclerosis. AJNR Am J Neuroradiol 26 (2005) 1548-1550
    • (2005) AJNR Am J Neuroradiol , vol.26 , pp. 1548-1550
    • Titelbaum, D.S.1    Degenhardt, A.2    Kinkel, R.P.3
  • 13
    • 0025852567 scopus 로고
    • Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
    • Selmaj K., Raine C.S., Cannella B., and Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87 (1991) 949-954
    • (1991) J Clin Invest , vol.87 , pp. 949-954
    • Selmaj, K.1    Raine, C.S.2    Cannella, B.3    Brosnan, C.F.4
  • 14
    • 0029316962 scopus 로고
    • Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors
    • Selmaj K.W., and Raine C.S. Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45 (1995) S44-S49
    • (1995) Neurology , vol.45
    • Selmaj, K.W.1    Raine, C.S.2
  • 15
    • 0025773147 scopus 로고
    • Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis
    • Sharief M.K., and Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325 (1991) 467-472
    • (1991) N Engl J Med , vol.325 , pp. 467-472
    • Sharief, M.K.1    Hentges, R.2
  • 16
    • 0035464263 scopus 로고    scopus 로고
    • Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
    • Robinson W.H., Genovese M.C., and Moreland L.W. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?. Arthritis Rheum 44 (2001) 1977-1983
    • (2001) Arthritis Rheum , vol.44 , pp. 1977-1983
    • Robinson, W.H.1    Genovese, M.C.2    Moreland, L.W.3
  • 17
    • 0029751983 scopus 로고    scopus 로고
    • Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
    • van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann F.W., von Blomberg B.M., et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47 (1996) 1531-1534
    • (1996) Neurology , vol.47 , pp. 1531-1534
    • van Oosten, B.W.1    Barkhof, F.2    Truyen, L.3    Boringa, J.B.4    Bertelsmann, F.W.5    von Blomberg, B.M.6
  • 18
    • 14944382276 scopus 로고    scopus 로고
    • Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha
    • Mitoma H., Horiuchi T., Hatta N., Tsukamoto H., Harashima S., Kikuchi Y., et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 128i (2005) 376-392
    • (2005) Gastroenterology , vol.128 i , pp. 376-392
    • Mitoma, H.1    Horiuchi, T.2    Hatta, N.3    Tsukamoto, H.4    Harashima, S.5    Kikuchi, Y.6
  • 20
    • 0030178426 scopus 로고    scopus 로고
    • Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis?
    • Hohlfeld R. Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis?. Mult Scler 1 (1996) 376-378
    • (1996) Mult Scler , vol.1 , pp. 376-378
    • Hohlfeld, R.1
  • 21
    • 0023221133 scopus 로고
    • Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system
    • Panitch H.S., Hirsch R.L., Schindler J., and Johnson K.P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37 (1987) 1097-1102
    • (1987) Neurology , vol.37 , pp. 1097-1102
    • Panitch, H.S.1    Hirsch, R.L.2    Schindler, J.3    Johnson, K.P.4
  • 22
    • 0030769165 scopus 로고    scopus 로고
    • The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire
    • Cope A., Ettinger R., and McDevitt H. The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire. Res Immunol 148 (1997) 307-312
    • (1997) Res Immunol , vol.148 , pp. 307-312
    • Cope, A.1    Ettinger, R.2    McDevitt, H.3
  • 25
    • 38049115514 scopus 로고    scopus 로고
    • Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature
    • Hamon M.A., Nicolas G., Deviere F., Letournel F., and Dubas F. Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature. Rev Neurol (Paris) 163 (2007) 1232-1235
    • (2007) Rev Neurol (Paris) , vol.163 , pp. 1232-1235
    • Hamon, M.A.1    Nicolas, G.2    Deviere, F.3    Letournel, F.4    Dubas, F.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.